Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB1280

Introduced
4/25/23  
Refer
4/25/23  

Caption

TRANQ Research Act of 2023 Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023

Impact

The implications of SB1280 extend to various areas of state and national public health law, as it seeks to address the challenges related to the increasing prevalence of dangerous psychoactive drugs. By promoting the development of better measurement technologies and analytical methods, the legislation looks to inform public health strategies and enhance drug enforcement efforts. This collaborative approach aims to equip law enforcement and health agencies with the tools needed to respond to the evolving landscape of drug abuse and ensure timely interventions.

Summary

Senate Bill 1280, known as the TRANQ Research Act of 2023, aims to enhance the capabilities of federal, state, and local agencies in the detection and analysis of new psychoactive substances, particularly xylazine and novel synthetic opioids. The bill mandates coordinated research and science activities conducted by the National Institute of Standards and Technology (NIST) to evaluate and develop advanced analytical methods, technologies, and practices for handling these substances. Through this legislation, there is a clear recognition of the growing challenge posed by new drugs in the illicit market and the necessity for improved detection mechanisms.

Sentiment

General sentiment around SB1280 appears to be supportive among public health advocates and lawmakers focused on improving drug safety. The bill presents a proactive measure to tackle an urgent issue within communities affected by drug abuse. However, there may be underlying concerns regarding the efficacy of implementing new technologies within existing frameworks and the potential need for substantial funding and resources to realize the bill's objectives. Stakeholders have expressed optimism that the increased focus on research and development can lead to significant advancements in the understanding and management of new psychoactive substances.

Contention

Notable points of contention surrounding the bill include discussions on the adequacy of existing federal resources and budget allocations to facilitate these research endeavors. Questions arise about how well these efforts will be integrated with state and local agencies, especially in varying jurisdictions with differing capabilities and priorities. Additionally, there is an ongoing debate among legislators regarding the balance between research investment and immediate implementation measures. The bill seeks not only to enhance detection capabilities but also to promote safe practices in the handling and analysis of these substances, indicating a comprehensive approach to addressing a multifaceted issue.

Companion Bills

US HB1734

Related Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 TRANQ Research Act of 2023

Similar Bills

US HB1734

Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 TRANQ Research Act of 2023

US SB3532

Youth Mental Health Data Act of 2023

US HB6601

TRAIN Act Training, Retention, And Investment Now for a Better America Act

US HB6095

Department of Defense PFAS Discharge Prevention Act

US HB6016

To improve coordination between the Department of Energy and the National Science Foundation on activities carried out under the National Quantum Initiative Program, and for other purposes.

US SB3337

DATA Privacy Act Digital Accountability and Transparency to Advance Privacy Act

US SB3545

Improving DATA in Public Health Act Improving Data Accessibility Through Advancements in Public Health Act

US HB6105

No Toxics in Food Packaging Act of 2023